Zuoqiang Bingpai Qin Fensanpian (左羟丙哌嗪分散片)左羟丙哌嗪分散片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 黑龙江乌苏里江制药有限公司哈尔滨分公司Chinese legal name: 黑龙江乌苏里江制药有限公司哈尔滨分公司
主要成分Active Ingredients
- 左羟丙哌嗪Zuoqiang Bingpai Qin
- 丙二醇Binger Chun
药物知识说明
左羟丙哌嗪是一种在国家药监局注册认定的药品。该药品含有丙二醇、左羟丙哌嗪-ddece3e1等成分。
该药品关联的活性成分包括：丙二醇Binger Chun、左羟丙哌嗪Zuoqiang Bingpai Qin。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：黑龙江乌苏里江制药有限公司哈尔滨分公司Chinese legal name: 黑龙江乌苏里江制药有限公司哈尔滨分公司。
您可以探索含有相同成分的其他药品：丙二醇-40961f6d成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 左羟丙哌嗪分散片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 丙二醇Binger Chun, 左羟丙哌嗪Zuoqiang Bingpai Qin.
Manufacturers recorded for this product: 黑龙江乌苏里江制药有限公司哈尔滨分公司Chinese legal name: 黑龙江乌苏里江制药有限公司哈尔滨分公司.
Explore other medicines containing the same ingredient: 丙二醇 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 左羟丙哌嗪分散片Recorded Chinese name: 左羟丙哌嗪分散片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 60mg60 mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 黑龙江乌苏里江制药有限公司哈尔滨分公司Chinese legal name: 黑龙江乌苏里江制药有限公司哈尔滨分公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20050758
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20050758
Manufacturer
Chinese legal name: 黑龙江乌苏里江制药有限公司哈尔滨分公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Keep sealed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20050758
生产企业
黑龙江乌苏里江制药有限公司哈尔滨分公司(国产)
适应症
由上呼吸道感染、咽炎、间质性肺炎、支气管哮喘和支气管炎等呼吸疾病引起的干咳和持续性咳嗽。
用法用量
1.口服，成年人一日三次，或每六小时以上一次，每次60mg，或遵医嘱。|2.一般连续服用两周后，建议停止服药，或遵医嘱。
不良反应
临床试验中，每100人中有4人服用本药后会有不良反应，但停药后会自行消失，不良反应：|1.胃肠方面有恶心、胃烧灼感、消化不良、腹泻等。|2.中枢神经方面有乏力、嗜睡、头痛、头晕等。|3.心血管方面有心悸。|4.偶有皮疹。
禁忌
已知或可能对药物极度过敏或痰多者禁用。
注意事项
因本药品偶尔会引起瞌睡，患者在驾驶或操作机器时慎用。
贮藏
密封。
规格
60mg
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.